UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer

Annals of nuclear medicine, 2021-11, Vol.35 (11), p.1214-1222

2021

Volltextzugriff (PDF)

Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer

BMC endocrine disorders, 2021-08, Vol.21 (1), p.160-160, Article 160

2021

Volltextzugriff (PDF)

Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years

Thyroid (New York, N.Y.), 2024-10, Vol.34 (10), p.1234-1245

2024

Volltextzugriff (PDF)

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients

Endokrynologia Polska, 2016, Vol.67 (1), p.2

2016

Volltextzugriff (PDF)

In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

European journal of nuclear medicine and molecular imaging, 2022-09, Vol.49 (11), p.3841-3851

2022

Volltextzugriff (PDF)

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes

Archives of medical science, 2022, Vol.18 (5), p.1241-1247

2022

Volltextzugriff (PDF)

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

Nuclear Medicine and Molecular Imaging , 2019, 53(5), , pp.320-327

2019

Volltextzugriff (PDF)

The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma

Endocrine Connections, 2020-01, Vol.9 (1), p.1-8

2020

Volltextzugriff (PDF)

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

Endokrynologia polska, 2018-01, Vol.69 (1), p.34-74

2018

Volltextzugriff (PDF)

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Thyroid research, 2010-11, Vol.3 (1), p.9-9

2010

Volltextzugriff (PDF)

Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy--a prospective study

Endokrynologia Polska, 2014, Vol.65 (1), p.40-45

2014

Volltextzugriff (PDF)

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

Thyroid research, 2009-08, Vol.2 (1), p.8-8, Article 8

2009

Volltextzugriff (PDF)

Recurrence patterns in differentiated thyroid cancer (DTC) following adjuvant radioiodine therapy

Endokrynologia Polska, 2024, Vol.75 (5), p.486-493

2024

Volltextzugriff (PDF)

Managing tyrosine kinase inhibitors side effects in thyroid cancer

Expert review of endocrinology & metabolism, 2017-03, Vol.12 (2), p.117-127

2017

Volltextzugriff (PDF)

Diagnostics and Treatment of Thyroid Carcinoma

Endokrynologia Polska, 2016, Vol.67 (1), p.74-145

2016

Volltextzugriff (PDF)

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

Thyroid research, 2013-04, Vol.6 (Suppl 2), p.A33-A33

2013

Volltextzugriff (PDF)

Comparison of clinical examination with orbital MRI evaluation in patients with thyroid orbitopathy - do we need imaging and when?

Thyroid research, 2013-04, Vol.6 (S2), p.A34-A34, Article A34

2013

Volltextzugriff (PDF)

False-positive radioiodine uptake in breasts in a female haemodialysis patient

Nuclear medicine review. Central & Eastern Europe, 2021-07, Vol.24 (2), p.122-123

2021

Volltextzugriff (PDF)

Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas

Endokrynologia polska, 2010-01, Vol.61 (1), p.43-48

2010

Volltextzugriff (PDF)

The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma

Endocrine Connections, 2019-11

2019

Volltextzugriff (PDF)

Rekomendacje Polskich Towarzystw Naukowych „Diagnostyka i leczenie raka tarczycy”. Aktualizacja na rok 2018

Endokrynologia polska, 2018-02, Vol.69 (1), p.34-74

2018

Volltextzugriff (PDF)

Ciągła stratyfikacja ryzyka w zróżnicowanym raku tarczycy (DTC) — stymulowane stężenie tyreoglobuliny (Tg) w surowicy, przed leczeniem uzupełniającym radiojodem (RAI), najważniejszym czynnikiem ryzyka nawrotu raka u pacjentów M0

Endokrynologia polska, 2016-02, Vol.67 (1), p.2-11

2016

Volltextzugriff (PDF)

Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?

Endokrynologia polska, 2006-09, Vol.57 (5), p.501-508

2006

Volltextzugriff (PDF)

Diagnosis and treatment of thyroid cancer - Polish guidelines

Endokrynologia polska, 2010-09, Vol.61 (5), p.518-568

2010

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(39)

Sprache

Englisch
(33)
Polnisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Humans
(14)
Endocrinology & Metabolism
(12)
Female
(11)
Male
(10)
Thyroid Cancer
(10)
Adult
(9)
Middle Aged
(9)
Thyroid Neoplasms - Pathology
(8)
Aged
(7)
Retrospective Studies
(7)
Iodine Radioisotopes - Therapeutic Use
(6)
Thyroidectomy
(6)
Young Adult
(6)
Adolescent
(5)
Iodine
(5)
Thyroid Neoplasms - Surgery
(5)
Care And Treatment
(4)
Differentiated Thyroid Cancer
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer

Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer

Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients

In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy--a prospective study

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

Recurrence patterns in differentiated thyroid cancer (DTC) following adjuvant radioiodine therapy

Managing tyrosine kinase inhibitors side effects in thyroid cancer

Diagnostics and Treatment of Thyroid Carcinoma

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

Comparison of clinical examination with orbital MRI evaluation in patients with thyroid orbitopathy - do we need imaging and when?

False-positive radioiodine uptake in breasts in a female haemodialysis patient

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas

The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma

Rekomendacje Polskich Towarzystw Naukowych „Diagnostyka i leczenie raka tarczycy”. Aktualizacja na rok 2018

Ciągła stratyfikacja ryzyka w zróżnicowanym raku tarczycy (DTC) — stymulowane stężenie tyreoglobuliny (Tg) w surowicy, przed leczeniem uzupełniającym radiojodem (RAI), najważniejszym czynnikiem ryzyka nawrotu raka u pacjentów M0

Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?

Diagnosis and treatment of thyroid cancer - Polish guidelines

Suchergebnisse filtern